CHINA PHARMA HOLDINGS, INC. CPHI Income Statement

China pharma holdings, inc. (CPHI)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenue
9,758	10,923	11,118	11,039	11,644	12,330	12,935	13,799	13,542	13,212	14,626	14,590	15,215	15,570	14,811	16,165	18,297	20,351	19,179	20,266	20,723	22,133	27,216	29,767	31,662	32,806	36,037	40,097	46,669	54,507	65,320	74,131	79,133	81,166	77,388	73,032	0	0	0
Cost of revenue
8,738	9,441	10,096	9,878	10,066	10,355	10,109	11,063	10,738	10,743	11,093	11,128	11,919	12,352	11,946	12,891	14,343	15,778	17,666	18,003	17,205	17,215	17,783	19,589	21,725	23,405	26,323	29,392	34,003	38,660	45,312	49,852	51,711	52,178	48,096	44,211	0	0	0
Inventory obsolescence
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,108	1,855	1,419	0	-	0	0	-	9,881	5,505	5,490	5,462	1,769	0	0	0	-	-	-	-	-	-
Gross profit
1,020	1,482	1,021	1,161	1,577	1,974	2,826	2,735	2,804	2,468	3,533	3,461	3,295	3,218	1,612	1,584	1,046	1,464	0	0	0	-	3,287	4,015	3,748	-480	4,208	5,214	7,202	14,076	20,008	24,279	27,422	28,988	29,291	28,820	0	0	0
Operating expenses:
Selling expenses
2,200	2,352	2,493	2,806	3,016	3,216	3,572	3,334	3,421	3,460	3,491	3,731	3,785	4,036	3,891	4,119	4,274	4,294	4,309	3,900	3,515	3,346	3,043	3,219	3,293	3,284	3,338	3,272	3,453	3,535	3,661	3,811	3,729	3,439	2,859	2,474	0	0	0
General and administrative expenses
2,249	2,289	1,874	1,868	1,886	1,949	1,814	1,836	2,095	2,019	2,249	2,194	2,363	2,265	1,974	2,064	1,743	1,896	1,803	1,841	1,765	1,716	2,096	2,046	2,255	2,404	2,324	2,549	2,771	2,874	3,278	3,301	3,475	3,716	3,398	3,671	0	0	0
Research and development expenses
208	229	240	262	220	172	123	88	86	90	151	223	298	365	509	816	894	961	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Bad debt expense
20	3	-822	275	615	604	1,920	1,021	1,035	1,393	1,035	735	865	1,086	14,255	11,164	7,528	10,147	12,970	20,071	31,244	31,352	18,122	17,460	14,181	10,752	8,057	4,951	431	871	1,018	770	418	108	-78	35	0	0	0
Impairment loss
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of long term assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Losses from natural disaster
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
21,693	21,890	10,265	11,691	12,218	12,422	19,453	19,486	20,822	21,148	11,584	11,002	11,275	11,717	22,203	19,092	14,544	17,404	20,094	28,876	41,316	41,490	28,365	25,724	21,690	18,125	16,136	12,837	7,854	8,313	7,958	7,884	7,623	7,264	6,179	6,181	0	0	0
Subsidy income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Subsidy income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Government subsidy income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0
Loss from operations
-20,672	-20,407	-9,243	-10,529	-10,640	-10,447	-16,627	-16,751	-18,018	-18,680	-8,054	-7,546	-7,636	-8,155	-20,260	-15,518	-11,858	-14,299	-5,122	0	0	-	0	-	-17,942	-18,606	-11,785	-7,480	-509	5,905	12,205	16,551	20,100	22,025	23,258	23,250	0	0	0
Income (loss) from operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income (expense):
Interest income
24	27	37	42	39	38	49	54	61	64	74	85	102	130	125	129	126	119	115	88	74	69	53	46	28	8	4	4	5	4	4	4	5	7	6	10	0	0	0
Interest expense
296	321	341	375	408	451	488	517	529	539	1,046	1,129	1,230	849	-1,865	-1,799	-1,721	-1,165	2,196	1,591	1,156	785	-744	-508	-487	-348	-171	-161	-148	-308	-305	-288	-271	-255	-222	-211	0	0	0
Net other expense
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-1,683	-1,622	-1,540	-1,045	1,985	1,426	1,037	716	-711	-481	-294	-340	-147	-138	-307	-303	0	0	0	-	-	-	-	-	-
Derivative gain
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	934	1,363	2,170	0	0	0
Net other expense
-272	-294	-303	-333	-369	-412	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	686	0	0	0	-	-
Loss before income taxes
-20,945	-20,702	-9,546	-10,863	-11,010	-10,860	-17,066	-17,213	-18,485	-19,154	-8,541	-8,105	-8,280	-8,874	-21,084	-16,404	-12,825	-15,345	-22,122	-31,382	-41,152	-39,473	-25,542	-22,008	-18,236	-18,946	-12,115	-7,801	-816	5,601	11,904	16,266	20,091	22,711	18,210	13,068	0	0	0
Income tax expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax expense;
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Income before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Income tax expense
-	-	-	-	-	-109	-81	110	118	122	0	0	0	-	0	0	-	-	0	-	-	-77	-1,472	-980	-1,349	-1,061	517	-199	-184	-983	-1,920	-2,603	-3,119	-3,442	-3,344	-3,049	0	0	0
Net loss
-20,945	-20,702	-9,548	-10,704	-10,874	-10,750	-16,985	-17,324	-18,604	-19,277	-8,876	-8,430	-8,596	-9,182	-21,151	-16,470	-12,889	-15,405	-6,337	-17,912	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-19,586	-20,008	-10,822	-7,224	-1,001	4,617	9,983	13,663	16,972	19,269	0	0	0	0	-
Other comprehensive income - foreign currency translation adjustment
-1,292	-259	-727	-1,352	-2,960	-2,122	-2,412	1,206	4,634	3,439	971	-1,387	-4,550	-4,549	-3,542	-7,061	-4,648	-4,693	-2,825	1,002	896	-653	-411	435	2,501	4,435	0	0	0	-	-	-	-	-	-	-	-	-	-
Other comprehensive income - foreign currency translation adjustment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,930	3,534	5,080	6,179	5,025	0	0	0
Comprehensive income (loss)
-22,237	-20,961	-10,276	-12,057	-13,834	-12,872	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15,594	20,506	24,349	27,241	27,196	0	0	0
Comprehensive loss
-	-	-	-	-	-	-	-	-	-	-	-9,818	-13,146	-13,732	-24,694	-23,531	-17,537	-20,098	-9,404	0	0	-	0	-	-17,085	-15,572	0	0	0	-	-	-	-	-	-	-	-	-	-
Other comprehensive income (loss) - foreign currency translation adjustment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Comprehensive income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Loss per share:
Basic and diluted
-0.02	-0.43	-0.02	-0.02	-0.01	-0.18	-0.04	-0.02	-0.01	-0.32	-0.05	-0.05	-0.02	-0.07	-0.04	-0.06	-0.04	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding
43,579	43,579	43,579	43,579	43,579	43,579	43,579	43,579	43,579	43,579	43,579	43,579	43,579	43,579	43,579	43,579	43,579	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.07	0.03	-0.09	-0.51	-0.15	-0.20	-0.05	-0.25	-0.05	-0.10	-0.06	-0.02	0.03	0.04	0.06	0.09	0.11	0.12	0.12	0.14	0.14
Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.07	0.03	-0.09	-0.51	-0.15	-0.20	-0.05	-0.25	-0.05	-0.10	-0.06	-0.02	0.03	0.04	0.06	0.09	0.11	0.12	0.12	0.14	0.14